Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines.

Hsieh MJ, Chen MK, Yu YY, Sheu GT, Chiou HL.

Phytomedicine. 2014 Jun 15;21(7):970-7. doi: 10.1016/j.phymed.2014.03.008. Epub 2014 Apr 2.

PMID:
24703328
2.

L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.

Chiu LY, Ko JL, Lee YJ, Yang TY, Tee YT, Sheu GT.

Toxicol Lett. 2010 Feb 15;192(3):408-18. doi: 10.1016/j.toxlet.2009.11.018. Epub 2009 Nov 26.

PMID:
19944135
3.

Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.

Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z.

Mol Med Rep. 2016 Jun;13(6):4745-50. doi: 10.3892/mmr.2016.5098. Epub 2016 Apr 8.

PMID:
27082231
4.

Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7.

Li W, Zhai B, Zhi H, Li Y, Jia L, Ding C, Zhang B, You W.

Tumour Biol. 2014 Sep;35(9):8883-91. doi: 10.1007/s13277-014-2101-z. Epub 2014 Jun 4.

PMID:
24894670
5.

Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.

Spengler G, Takács D, Horváth A, Riedl Z, Hajós G, Amaral L, Molnár J.

Anticancer Res. 2014 Apr;34(4):1737-41.

PMID:
24692704
6.

Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.

Ye MX, Zhao YL, Li Y, Miao Q, Li ZK, Ren XL, Song LQ, Yin H, Zhang J.

Phytomedicine. 2012 Jun 15;19(8-9):779-87. doi: 10.1016/j.phymed.2012.03.005. Epub 2012 Apr 4.

PMID:
22483553
7.

Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.

Zhou WJ, Zhang X, Cheng C, Wang F, Wang XK, Liang YJ, To KK, Zhou W, Huang HB, Fu LW.

Br J Pharmacol. 2012 Jul;166(5):1669-83. doi: 10.1111/j.1476-5381.2012.01849.x.

8.

FG020326 sensitized multidrug resistant cancer cells to docetaxel-mediated apoptosis via enhancement of caspases activation.

Wang XW, Wang XK, Zhang X, Liang YJ, Shi Z, Chen LM, Fu LW.

Molecules. 2012 May 9;17(5):5442-58. doi: 10.3390/molecules17055442.

9.

Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells.

Ma W, Feng S, Yao X, Yuan Z, Liu L, Xie Y.

Sci Rep. 2015 Dec 22;5:18789. doi: 10.1038/srep18789.

10.

Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.

Liu DL, Li YJ, Yao N, Xu J, Chen ZS, Yiu A, Zhang CX, Ye WC, Zhang DM.

Eur J Pharmacol. 2014 Jun 15;733:34-44. doi: 10.1016/j.ejphar.2014.03.043. Epub 2014 Apr 4.

PMID:
24704556
11.

Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.

Li WJ, Zhong SL, Wu YJ, Xu WD, Xu JJ, Tang JH, Zhao JH.

Mol Biol Rep. 2013 Nov;40(11):6143-50.

PMID:
24078162
12.

Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.

Takács D, Csonka Á, Horváth Á, Windt T, Gajdács M, Riedl Z, Hajós G, Amaral L, Molnár J, Spengler G.

Anticancer Res. 2015 Jun;35(6):3245-51.

PMID:
26026084
13.

Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells.

Kim EH, Min HY, Chung HJ, Song J, Park HJ, Kim S, Lee SK.

Food Chem Toxicol. 2012 Mar;50(3-4):1060-5. doi: 10.1016/j.fct.2011.11.008. Epub 2011 Nov 20.

PMID:
22120505
14.

Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line.

Dong Y, Shao S, Hu J, Yang P.

Oral Oncol. 2009 Nov;45(11):991-7. doi: 10.1016/j.oraloncology.2009.05.642. Epub 2009 Jul 23.

PMID:
19631573
15.

Reversal of multidrug resistance in vitro and in vivo by 5-N-formylardeemin, a new ardeemin derivative.

Zheng X, Li D, Zhao C, Wang Q, Song H, Qin Y, Liao L, Zhang L, Lin Y, Wang X.

Apoptosis. 2014 Aug;19(8):1293-300. doi: 10.1007/s10495-014-0998-8.

PMID:
24858827
16.

Effects of Psoralen as an Anti-tumor Agent in Human Breast Cancer MCF-7/ADR Cells.

Wang X, Cheng K, Han Y, Zhang G, Dong J, Cui Y, Yang Z.

Biol Pharm Bull. 2016 May 1;39(5):815-22. doi: 10.1248/bpb.b15-00957. Epub 2016 Feb 19.

17.

Epithelial-mesenchymal transition contributes to docetaxel resistance in human non-small cell lung cancer.

Shen W, Pang H, Liu J, Zhou J, Zhang F, Liu L, Ma N, Zhang N, Zhang H, Liu L.

Oncol Res. 2014;22(1):47-55. doi: 10.3727/096504014X14098532393473.

PMID:
25700358
18.

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.

Collins DM, Crown J, O'Donovan N, Devery A, O'Sullivan F, O'Driscoll L, Clynes M, O'Connor R.

Invest New Drugs. 2010 Aug;28(4):433-44. doi: 10.1007/s10637-009-9266-0. Epub 2009 Jun 5.

PMID:
19499189
19.

Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein.

Zhang Y, Liu X, Zuo T, Liu Y, Zhang JH.

Med Oncol. 2012 Jun;29(2):534-8. doi: 10.1007/s12032-011-9950-8. Epub 2011 May 12.

PMID:
21562851
20.

β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.

Yao CC, Tu YR, Jiang J, Ye SF, Du HX, Zhang Y.

Oncol Rep. 2014 May;31(5):2131-8. doi: 10.3892/or.2014.3083. Epub 2014 Mar 12.

PMID:
24627125

Supplemental Content

Support Center